|
1
|
Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study.
|
Arch Neurol
|
2008
|
1.96
|
|
2
|
Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.
|
Eur J Hum Genet
|
2006
|
1.56
|
|
3
|
Validity of family history data on primary adult-onset dystonia.
|
Arch Neurol
|
2004
|
1.05
|
|
4
|
Predictors of long survival in amyotrophic lateral sclerosis: a population-based study.
|
J Neurol Sci
|
2007
|
1.05
|
|
5
|
Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.
|
J Neurol Sci
|
2006
|
1.01
|
|
6
|
Lack of habituation of nociceptive evoked responses and pain sensitivity during migraine attack.
|
Clin Neurophysiol
|
2005
|
0.96
|
|
7
|
Novel parkin mutations detected in patients with early-onset Parkinson's disease.
|
Mov Disord
|
2005
|
0.94
|
|
8
|
Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study.
|
Mov Disord
|
2010
|
0.90
|
|
9
|
Habituation of single CO2 laser-evoked responses during interictal phase of migraine.
|
J Headache Pain
|
2005
|
0.89
|
|
10
|
Sleep disorders and the natural history of Parkinson's disease: the contribution of epidemiological studies.
|
Sleep Med Rev
|
2010
|
0.89
|
|
11
|
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy.
|
J Neurol
|
2007
|
0.88
|
|
12
|
Laser-evoked potentials habituation in fibromyalgia.
|
J Pain
|
2010
|
0.88
|
|
13
|
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
|
Mov Disord
|
2009
|
0.86
|
|
14
|
Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses.
|
Curr Vasc Pharmacol
|
2006
|
0.85
|
|
15
|
Influence of MTHFR genotype on contingent negative variation and MRI abnormalities in migraine.
|
Headache
|
2007
|
0.84
|
|
16
|
Reversible Parkinsonian syndrome associated with anti-neuronal antibodies in acute EBV encephalitis: a case report.
|
Parkinsonism Relat Disord
|
2006
|
0.83
|
|
17
|
Primary angiitis of the central nervous system: a misinterpreted clinical onset of CNS vasculitis.
|
Eur Neurol
|
2005
|
0.82
|
|
18
|
Reproductive factors and Parkinson's disease: a multicenter case-control study.
|
Mov Disord
|
2011
|
0.81
|
|
19
|
Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.
|
Parkinsonism Relat Disord
|
2013
|
0.81
|
|
20
|
Current and emerging treatments for amyotrophic lateral sclerosis.
|
Neuropsychiatr Dis Treat
|
2009
|
0.81
|
|
21
|
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesias.
|
Clin Chem Lab Med
|
2006
|
0.81
|
|
22
|
Motoneuron disease after electric injury: a case report.
|
Neurol Sci
|
2008
|
0.81
|
|
23
|
Intra-oral orthosis vs amitriptyline in chronic tension-type headache: a clinical and laser evoked potentials study.
|
Head Face Med
|
2006
|
0.81
|
|
24
|
Topographic analysis of laser evoked potentials in chronic tension-type headache: correlations with clinical features.
|
Int J Psychophysiol
|
2006
|
0.80
|
|
25
|
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions.
|
Clin Chem Lab Med
|
2005
|
0.80
|
|
26
|
Tertiary treatment for psychiatric comorbidity in headache patients.
|
J Headache Pain
|
2005
|
0.80
|
|
27
|
Effects of high-frequency repetitive transcranial magnetic stimulation of primary motor cortex on laser-evoked potentials in migraine.
|
J Headache Pain
|
2010
|
0.80
|
|
28
|
The FRAGAMP study: environmental and genetic factors in Parkinson's disease, methods and clinical features.
|
Neurol Sci
|
2010
|
0.79
|
|
29
|
Effects of remote cutaneous pain on trigeminal laser-evoked potentials in migraine patients.
|
J Headache Pain
|
2007
|
0.79
|
|
30
|
Capsaicin failed in suppressing cortical processing of CO2 laser pain in migraine patients.
|
Neurosci Lett
|
2005
|
0.79
|
|
31
|
The comorbidity of migraine and hypertension. A study in a tertiary care headache centre.
|
J Headache Pain
|
2005
|
0.78
|
|
32
|
Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy.
|
Epilepsia
|
2008
|
0.78
|
|
33
|
The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
|
Mov Disord
|
2006
|
0.77
|
|
34
|
Wine drinking and essential tremor: a possible protective role.
|
Mov Disord
|
2011
|
0.77
|
|
35
|
Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease.
|
Mov Disord
|
2010
|
0.76
|
|
36
|
A case of vacuolar myopathy during the course of chronic hepatitis C.
|
Funct Neurol
|
2006
|
0.76
|
|
37
|
Antiparkinsonian treatment in pregnancy.
|
Mov Disord
|
2002
|
0.75
|
|
38
|
Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review.
|
Clin Chem Lab Med
|
2007
|
0.75
|
|
39
|
Unusual clinical presentation of a patient carrying a novel single 1.8 kb deletion of mitochondrial DNA.
|
Funct Neurol
|
2006
|
0.75
|